Mysterious gene transcripts after cancer therapy

gene
Credit: CC0 Public Domain

Tumor suppressor genes protect cells from malignant transformation. If they are turned off as a result of chemical modifications in DNA, called epigenetic labels, this contributes to the development of cancer. As opposed to gene mutations, these epigenetic changes are reversible and it is possible to use specific drugs to erase them.

"This has been successfully done for years now in various cancers such as and myelodysplastic syndrome," said Christoph Plass from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg. He added that it has also been proven that dangerous labels such as on can be removed in this way. "However, the agents pass over the DNA like a lawn mower and remove practically all labels," said Plass. "And so far nobody has studied in detail what effect this has on the ."

Plass and his co-workers have now pursued this question in collaboration with colleagues from the U.S.A. Using genome-wide analyses, the scientists discovered that countless mysterious gene transcripts arise in the wake of treatment. This is due to an activation of specific in DNA, called promoters, which have been largely unnoticed so far. "There is total chaos in the treated cancer cells - we hadn't expected that," said David Brocks, who is one of the first authors of the study.

A closer look has shown that the activated regulatory elements originate from viruses that inserted themselves into the genome in the ancient past. However, they were turned off in the course of evolution, thus becoming normal components of DNA.

Protein fragments that form on the basis of these peculiar gene transcripts have the potential to be recognized by the immune system and, thus, to stimulate the immune system. This might increase the effectiveness of drugs that are being used. "Now we have to investigate whether this effect can be used specifically to improve therapy," Plass said. And yet another aspect: "These gene transcripts might be useful as biomarkers to examine whether an epigenetic therapy is effective and reasonable in the individual patient."


Explore further

DNA methylation pattern in leukemia only appears to be cancer-typical

More information: "DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats," Nature Genetics (2017). DOI: 10.1038/ng.3889
Journal information: Nature Genetics

Provided by German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Citation: Mysterious gene transcripts after cancer therapy (2017, June 12) retrieved 23 July 2019 from https://medicalxpress.com/news/2017-06-mysterious-gene-transcripts-cancer-therapy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
116 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more